|
H1F0 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.21590000015759E-07 |
| Normal-vs-Stage3 |
6.17239592770602E-12 |
| Normal-vs-Stage4 |
1.64079860809352E-12 |
| Stage1-vs-Stage2 |
5.628400E-01 |
| Stage1-vs-Stage3 |
8.823800E-01 |
| Stage1-vs-Stage4 |
4.183700E-03 |
| Stage2-vs-Stage3 |
5.673400E-01 |
| Stage2-vs-Stage4 |
3.317900E-02 |
| Stage3-vs-Stage4 |
3.088000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.37361258320834E-12 |
| Normal-vs-AfricanAmerican |
8.42830000000738E-05 |
| Normal-vs-Asian |
2.94253510446651E-12 |
| Caucasian-vs-AfricanAmerican |
2.457000E-01 |
| Caucasian-vs-Asian |
1.738380E-01 |
| AfricanAmerican-vs-Asian |
1.177370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54769530524845E-11 |
| Normal-vs-Female |
4.96724883447541E-12 |
| Male-vs-Female |
5.182800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.07129885360291E-12 |
| Normal-vs-Age(41-60Yrs) |
1.33226762955019E-15 |
| Normal-vs-Age(61-80Yrs) |
1.3233999451856E-09 |
| Normal-vs-Age(81-100Yrs) |
6.995500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.801800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.995200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.406200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.453600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.615600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.136600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.031600E-02 |
| Classical-VS-Follicular |
2.523800E-01 |
| Classical-VS-Other |
9.821000E-01 |
| Classical-VS-Normal |
9.82092185353167E-12 |
| Tall-VS-Follicular |
2.746200E-02 |
| Tall-VS-Other |
6.326400E-01 |
| Tall-VS-Normal |
4.87165863205519E-13 |
| Follicular-VS-Other |
7.354600E-01 |
| Follicular-VS-Normal |
3.566100004182E-08 |
| Other-VS-Normal |
3.244100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77475828372553E-15 |
| Normal-vs-N1 |
1.71007652483013E-12 |
| N0-vs-N1 |
1.762050E-02 |
|
|
